Clover Health Investments, Corp. reported a 27% increase in year-over-year Medicare Advantage membership during the recent Annual Election Period, reaching over 100,000 members, with 95% enrolled in ...

Clover Biopharma reports additional positive US phase I clinical data for RSV re-vaccination in older adults: Shanghai Thursday, March 26, 2026, 16:00 Hrs [IST] Clover Biopharmace ...

Robust plan benefits powered member growth, mainly driven by switchers from other plans Company will focus on balancing profitability with strategic investments in growth and technology to take ...

Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 ...

For the first time as a public company, Clover Health is announcing its first quarterly net profit, the company said ahead of its second quarter earnings call. Clover declared a net income of $7.2 ...

Clover Health Investments Corp ( (CLOV)) has released its Q3 earnings. Here is a breakdown of the information Clover Health Investments Corp presented to its investors. Clover Health Investments Corp.

Clover provides preliminary 2022 MA guidance: Average MA Lives of 82,000, up 20% plus year-over-year, and MA MCR in the range of 95% to 99% "Our mission is to improve every life; we do so by providing ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Clover Biopharmaceuticals Ltd. ( (HK:2197 ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health (CLOV) Investments announced a 27% year-over-year growth of its Medicare Advantage, MA, membership during the most recent Annual Election Period, AEP. The Company enters 2025 with over ...